Testing

Hepatitis Assays Shown Useful in Developing Areas

Published in Hepatitis Weekly, July 22nd, 1996

Newly developed hepatitis assays are simple to perform and inexpensive, making them suitable for testing populations in developing areas, according to a report from the World Health Organization.

While there are a large variety of serological assays available for diagnosing HIV infection, there are far fewer assays for detecting hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. An enzyme immunoassay (EIA) is most often used to detect HBV surface antigen (HBsAg) and antibodies to HCV.

Although EIAs are highly accurate and applicable in many situations, alternatives are available and may be needed for remote or economically challenged...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1996-07-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry